Effectiveness of a Structured Intervention to Optimize the Use of Mirabegron
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Antonio Aranzana Martínez, Physician
Director. Primary Health Care Center Rio de Janeiro
Study Chair - Eladio Fernández-Liz, PhD
Pharmacist
Principal Investigator - José Ossó Rebull, Physician
Director. Primary Health Care Center Sant Andreu
Study Chair - María José López-Dolcet, Physician
Director. Primary Health Care Center Service Muntanya
Study Chair - Mª Estrella Barceló Colomer, Physician
Clinical Pharmacologist
Study Chair - Pedro Vivó Tristante, Physician
Director. Primary Health Care Center Montcada i Reixac
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jan 2017
- Primary completion
- 31 Dec 2017
- Completion
- 31 Dec 2017
- Last update posted
- 7 Nov 2018
- Registered enrollment
- 1,932
- Registry id
- NCT03536494
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.